Pharsight

Avandamet patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8236345 SB PHARMCO Composition and use
Oct, 2022

(1 year, 5 months ago)

Avandamet is owned by Sb Pharmco.

Avandamet contains Metformin Hydrochloride; Rosiglitazone Maleate.

Avandamet has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Avandamet are:

  • US8236345

Avandamet was authorised for market use on 10 October, 2002.

Avandamet is available in tablet;oral dosage forms.

The generics of Avandamet are possible to be released after 07 October, 2022.

Drugs and Companies using METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE ingredient

Market Authorisation Date: 10 October, 2002

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of AVANDAMET before it's drug patent expiration?
More Information on Dosage

AVANDAMET family patents

Family Patents